---
title: "Embecta Corp. (EMBC.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/EMBC.US.md"
symbol: "EMBC.US"
name: "Embecta Corp."
industry: "Health Care Supplies"
---

# Embecta Corp. (EMBC.US)

| Item | Detail |
|------|--------|
| Industry | Health Care Supplies |
| Location | US Market |
| Website | [www.embecta.com](https://www.embecta.com) |

## Company Profile

Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company’s products include pen needles, syringes, and safety injection devices, as well as digital applications to assist peopl...

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-16T04:30:14.000Z

**Overall: C (0.55)**

**Industry**: Health Care Supplies

| Metric | Value |
|--------|-------|
| Industry Ranking | 19 / 43 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -2.53% |  |
| Net Profit YoY | 139.69% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | -0.98 |  |
| Dividend Ratio | 5.90% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 602.27M |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 1.08B |  |


**Multi Score**: C

#### Profit Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -20.19% | E |
| Profit Margin | 12.92% | B |
| Gross Margin | 61.91% | A |

#### Growth Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -2.53% | D |
| Net Profit YoY | 139.69% | A |
| Total Assets YoY | -7.46% | D |
| Net Assets YoY | 20.25% | A |

#### Cash Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | 773.98% | B |
| OCF YoY | -2.53% | D |

#### Operating Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.98 | A |

#### Debt Score: E

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 157.64% | E |


```chart-data:radar
{
  "title": "Longbridge Financial Score - Embecta Corp.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "-20.19%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "12.92%",
          "rating": "B"
        },
        {
          "name": "Gross Margin",
          "value": "61.91%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "C",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-2.53%",
          "rating": "D"
        },
        {
          "name": "Net Profit YoY",
          "value": "139.69%",
          "rating": "A"
        },
        {
          "name": "Total Assets YoY",
          "value": "-7.46%",
          "rating": "D"
        },
        {
          "name": "Net Assets YoY",
          "value": "20.25%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "C",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "773.98%",
          "rating": "B"
        },
        {
          "name": "OCF YoY",
          "value": "-2.53%",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "A",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.98",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "E",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "157.64%",
          "rating": "E"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | Essilor (US.ESLOY) | B | B | C | B | B | B |
| 02 | HOYA Corporation (US.HOCPY) | A | B | B | A | C | B |
| 03 | Align (US.ALGN) | B | C | B | B | C | B |
| 04 | Merit Medical (US.MMSI) | B | B | B | C | B | B |
| 05 | UFP Tech (US.UFPT) | B | B | A | B | B | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 4.32 | 3/44 | 12.42 | 10.54 | 7.82 |
| PB | -0.98 | 41/44 | - | - | - |
| PS (TTM) | 0.56 | 6/44 | 0.74 | 0.66 | 0.57 |
| Dividend Yield | 5.90% | 1/44 | 5.69% | 4.84% | 4.28% |

## Institutional View

### Analyst Rating Distribution

> As of 2026-02-06T05:00:00.000Z

Total Analysts: **4**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 1 | 25% |
| Overweight | 0 | 0% |
| Hold | 2 | 50% |
| Underweight | 1 | 25% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 10.17 |
| Highest Target | 25.00 |
| Lowest Target | 11.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/EMBC.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/EMBC.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/EMBC.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.
